Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Apply
Mirdametinib & Vorinostat
A Window of Opportunity Trial of Mirdametinib Plus Vorinostat for NF1 Associated, H3K27 Trimethylation Deficient Malignant Peripheral Nerve Sheath Tumor [MPNST]
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step